Literature DB >> 2913426

High-activity iodine-125 endocurietherapy for head and neck tumors.

P P Kumar1, R R Good, A J Yonkers, F P Ogren.   

Abstract

Inoperable solid tumor recurrence within a surgical bed or within a previously irradiated field usually responds poorly to re-treatment with conventional external beam irradiation (EXRT) and/or chemotherapy. We present a new, alternative method of re-treatment used in two patients with recurrent head and neck cancer involving the parotid (adenocarcinoma) and neck nodes (squamous cell carcinoma). These patients were successfully re-treated with high-activity 125iodine (I-125) permanent implantation.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2913426     DOI: 10.1288/00005537-198902000-00009

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  1 in total

1.  Retreatment of advanced esthesioneuroblastoma with high-activity I-125 endocurietherapy: a case report.

Authors:  P P Kumar; F P Ogren; R D McComb; E O Jones; G F McCaul
Journal:  J Natl Med Assoc       Date:  1991-08       Impact factor: 1.798

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.